Thank you for subscribing to our blog.
We’ll hit your inbox next week with our latest post.

Latest Insights and Updates Delivered to your Inbox!

Subscribe now for exciting weekly industry news!

Expert PK/PD Statistical Data Analysis Services for Trial Efficiency
Pharmacokinetic (PK) and pharmacodynamic (PD) studies provide critical insights into how a drug is processed by the body (PK) and how it exerts its effects (PD). For pharmaceutical sponsors and biotech companies, especially those working in oncology, understanding and leveraging PK/PD data is crucial from early-stage trials through regulatory submi...
Webinar Spotlight: Parkinson’s Disease and the Role of Genetics in Neurology Clinical Trials
Genetic Insights in Parkinson’s Disease Research Parkinson’s disease (PD), a progressive neurodegenerative disorder, affects more than 10 million people worldwide. With global prevalence expected to double by 2040, the urgency for innovative Parkinson’s disease treatment solutions continues to grow. As the scientific community ...
Why Working with Navitas Supports the Planet
Enabling Your ESG Goals Through Ours World Environment Day 2025 spotlights how organizations across sectors can meaningfully reduce their environmental footprint and strengthen sustainability reporting. For the life sciences industry—often associated with high resource consumption, extensive logistics, and complex supply chains—sustai...
Pharma Regulatory Services in the US: Case Studies of How Navitas Life Sciences Supports Strategic Submissions for Market Success
The United States remains a global leader in the life sciences industry, offering immense opportunities for pharmaceutical and medical device companies worldwide. As one of the most advanced and tightly regulated markets, U.S. requires strict adherence to the U.S. Food and Drug Administration’s (FDA) evolving guidelines. The complex regulato...
International Clinical Trials Day 2025: Collaborate, Innovate, Advance with Navitas Life Sciences
International Clinical Trials Day is celebrated on May 20 to honour clinical research advancements. International Clinical Trials Day 2025 is celebrated globally on May 20th to recognize the very first controlled trial by James Lind in 1747 and to honour the contributions of researchers, patients, and sponsors in advancing medical science. This yea...
Navitas Life Sciences Empowers Emerging Biopharma to Accelerate Innovation
Built for Biotech. Start Smart. Scale Fast. Breakthrough science begins with bold ambition and realizing its potential takes the right partner. As an experienced Biotech CRO, Navitas Life Sciences recognizes the unique challenges that emerging biopharma and biotech innovators face: limited resources, accelerated timelines, and the critical need to ...
Consumer Healthcare Product Safety: What now, Where Next?
The inaugural Consumer Healthcare (CHC) Safety Roundtable, hosted by Navitas pvnetworks and led by industry leaders Dr. Latika Sharma, MBBS, MD, Ben Parsons, and Dr. Sara Hall, PhD, served as a pivotal gathering for discussing the evolving landscape of consumer healthcare product safety. In this exclusive event, distinguished industry experts, Viny...
Parkinson’s Foundation’s PD GENEration Study: Strategic Partnership with Navitas Life Sciences
As the world observes World Parkinson’s Day on April 11th, a day dedicated to raising awareness about Parkinson’s disease and honouring Dr. James Parkinson, who first described the condition in 1817, the spotlight turns to groundbreaking initiatives that harness genetic research to transform patient care. One such initiative, PD GENEr...
World Health Day 2025: Maternal and Newborn Health
On April 7, 2025, we join the World Health Organisation, under the banner of Healthy beginnings, hopeful futures. The World Health Day 2025 campaign urges stakeholders to take decisive action against preventable maternal and newborn deaths. Over 300,000 women lose their lives annually due to pregnancy or childbirth, and 4 million newborns die or ar...
Reimagining Medical Writing – Data, Digital, and Automation
The pharmaceutical industry is experiencing a paradigm shift in medical writing, driven by artificial intelligence (AI), structured content authoring, and automation. Navitas Life Sciences’ 3rd Medical Writing Roundtable, hosted by Dr Latika Sharma and Dr. Sara Giadrossi, brought together industry leaders from 10+ global pharmaceutical compa...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us